Gut microbiota modulation in the chronic kidney disease management
Chronic kidney disease (CKD) is a systemic disease that develops as a consequence of progressive and irreversible damage to the structure of the kidneys, which leads to impairment of the homeostatic excretory, metabolic and regulatory functions of the kidneys. The final consequence is end-stage rena...
Main Author: | Łukasz Dobrek |
---|---|
Format: | Article |
Language: | Polish |
Published: |
Polish Pharmaceutical Society
2022-03-01
|
Series: | Farmacja Polska |
Subjects: | |
Online Access: | https://www.ptfarm.pl/download/?file=File%2FFarmacja+Polska%2F2022%2F1%2F02_OG_Gut_microbiota_modulation_n.pdf |
Similar Items
-
The Gut–Kidney Axis in Chronic Kidney Diseases
by: Kenji Tsuji, et al.
Published: (2024-12-01) -
The modulation of gut microbiota by herbal medicine to alleviate diabetic kidney disease – A review
by: Jinxin Du, et al.
Published: (2022-11-01) -
Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives
by: Themistoklis Katsimichas, et al.
Published: (2023-02-01) -
Berberine ameliorates chronic kidney disease through inhibiting the production of gut-derived uremic toxins in the gut microbiota
by: Libin Pan, et al.
Published: (2023-04-01) -
Effects of a high-prebiotic diet versus probiotic supplements versus synbiotics on adult mental health: The “Gut Feelings” randomised controlled trial
by: Tanya M. Freijy, et al.
Published: (2023-02-01)